US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CRO Concept

1,514.91

-34.5928-2.23%

Number of Gainers:- -

Number of Losers:2

Number of Flat:1

PE:- -

High:1,556.78

Open:1,547.65

Low:1,507.86

Close:1,549.50

Volume:1.79M

Turnover:313.68M

Market Cap:38.04B

Float Cap:36.53B

Loading ...

Charles River Labs cuts 2026 revenue outlook and lifts non-GAAP EPS forecast

IQVIA to Acquire Drug Discovery Assets From Charles River Laboratories

IQVIA Signs Agreement to Acquire Drug Discovery Assets From Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

THOMSON REUTERS

Gartner Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Supernus Pharmaceuticals to Participate in March Investor Conferences

A Look At IQVIA Holdings (IQV) Valuation After Strong 2025 Results And New Obesity Research Collaboration

Simply Wall St.

IQVIA Holdings Inc : Mizuho Cuts Target Price to $215 From $266

THOMSON REUTERS

Charles River Laboratories International Inc : TD Cowen Cuts Target Price to $235 From $251

THOMSON REUTERS

Gartner Inc. Stock Underperforms Thursday When Compared To Competitors

Charles River Labs Is Maintained at Outperform by Evercore ISI Group

Iqvia price target lowered to $245 from $290 at Truist

Charles River price target lowered to $200 from $260 at Evercore ISI

Charles River Labs : Barclays Cuts Target Price to $200 From $215

THOMSON REUTERS

Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns

Charles River Laboratories International Inc : Baird Cuts Target Price to $193 From $231

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4530/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":1514.911,"timestamp":1772830146503,"preClose":1549.5038,"halted":0,"volume":1785853,"delay":0,"changeRate":-0.022325,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-34.592773,"latestTime":"03-06 15:49:06 EST","open":1547.65,"high":1556.7828,"low":1507.8589,"amount":313681838.829111,"amplitude":0.031574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772830800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.00309,"peRate":31.83483,"turnoverRate":0.00856,"increases":0,"decrements":2,"flats":0,"marketCap":38039273472,"floatMarketCap":36534821376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1556.7828,"amplitude":0.031574,"preClose":1549.5038,"low":1507.8589,"pbRate":"4.00309","latestPrice":1514.911,"volume":1785853,"delay":0,"open":1547.65,"prevYearClose":1899.2574,"prevWeekClose":1546.1846,"prevMonthClose":1546.1846,"prevQuarterClose":1899.2574,"fiveDayClose":1546.1846,"twentyDayClose":1569.3436,"sixtyDayClose":1862.3478,"secType":"PLATE","market":"US","turnoverRate":0.00856,"peRate":31.83483,"marketCap":38039273472,"floatMarketCap":36534821376,"timestamp":1772830146503,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":0,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614089216","title":"Charles River Labs cuts 2026 revenue outlook and lifts non-GAAP EPS forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089216","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089216?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020833,"startTime":"0","endTime":"0","summary":"Charles River Laboratories updated its 2026 outlook to reflect planned divestitures expected to close in the second quarter of 2026. Reported revenue is now forecast to decline 3.5% to 5.0% in 2026, compared with its prior view of at least flat to up 1.5%, as the divestitures are expected to reduce reported revenue by slightly more than $200 million and trim organic growth by more than 50 basis points. Despite the lower revenue base, the company raised its non-GAAP EPS range to $10.80 to $11.30 from $10.70 to $11.20, citing at least 100 basis points of incremental non-GAAP operating margin improvement and about $0.10 of partial-year EPS accretion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLC0Gzg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4121","LU0390134368.USD","BK4588","LU0757428866.USD","LU0128526141.USD","IE00BFMHRM44.USD","BK4585","LU0029874061.USD","CRL","LU1815336091.USD"],"gpt_icon":0},{"id":"2614089215","title":"IQVIA to Acquire Drug Discovery Assets From Charles River Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089215","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089215?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020826,"startTime":"0","endTime":"0","summary":"IQVIA has agreed to acquire certain drug discovery services assets from Charles River Laboratories, including five sites providing in vitro discovery services, established lab-based New Approach Methodologies and a small molecule AI platform. IQVIA said the deal will expand IQVIA Laboratories’ end-to-end drug discovery capabilities from target identification through early safety assessment and is expected to close in the second quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLyj3hP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","LU1201861165.SGD","LU1201861249.SGD","LU0757428866.USD","LU0980610538.SGD","LU0128526141.USD","LU0029874061.USD","IE00BFMHRM44.USD","BK4121","LU0130103400.USD","LU0477156797.USD","CRL","BK4530","LU0390134368.USD","BK4588","LU0130102774.USD","LU0130517989.USD","LU1791710582.SGD","LU1989764748.USD","LU1815336091.USD","BK4585","LU0882574055.USD","LU1791710400.SGD","IQV","LU1989764664.SGD","LU0130518102.USD","LU0477156953.USD","LU0528227936.USD","LU0648001328.SGD","LU0198837287.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2614089486","title":"IQVIA Signs Agreement to Acquire Drug Discovery Assets From Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089486?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUAB4BDBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU1791710400.SGD","LU0648000940.SGD","LU0130102774.USD","BK4588","LU0198837287.USD","LU0980610538.SGD","LU1989764748.USD","LU0130103400.USD","BK4121","LU0130517989.USD","LU0130518102.USD","LU1201861165.SGD","IQV","LU0528227936.USD","LU1989764664.SGD","BK4585","LU0477156953.USD","LU1261432733.SGD","LU1201861249.SGD","LU0648001328.SGD","LU1791710582.SGD","BK4530","LU0477156797.USD"],"gpt_icon":0},{"id":"2614172691","title":"Gartner Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2614172691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614172691?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:19","pubTimestamp":1771971540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gartner Inc.  rose 1.63% to $147.34 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.77% to 6,890.07 and the Dow Jones Industrial Average  rising 0.76% to 49,174.50.The stock's rise snapped a three-day losing streak.Gartner Inc. closed 70.98% short of its 52-week high of $507.79, which the company reached on February 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Trade Desk Inc. Cl A  rose 3.19% to $24.94, IQVIA Holdings Inc.  rose 1.58% to $164.88, and Omnicom Group Inc.  rose 2.12% to $82.46.Trading volume  eclipsed its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","BK4023","LU0731783048.USD","LU1481011911.USD","BK4548","LU1989764664.SGD","TTD","OMC","LU0477156953.USD","BK4009","BK4528","BK4588","LU2517655028.SGD","BK4530","LU1548497426.USD","LU0980610538.SGD","LU0528227936.USD","BK4613","LU0130102774.USD","LU1599440770.SGD","LU0321505868.SGD","LU0882574055.USD","LU0107464264.USD","LU0321505439.SGD","BK4134","LU0348723411.USD","LU0154245756.USD","IE00BFXG1179.USD","LU1791710582.SGD","IT","LU0130517989.USD","LU0731783394.SGD","LU0130103400.USD","LU1261432733.SGD","LU1481011671.HKD","LU0198837287.USD","LU1989764748.USD","LU2357305700.SGD","LU2362541513.USD","TTDU","BK4121","LU1814569148.SGD","IQV","LU2517655374.HKD","LU0154245673.USD","LU0648001328.SGD","LU2362541273.HKD","LU1201861165.SGD","LU1791710400.SGD","LU2362540622.SGD"],"gpt_icon":0},{"id":"2613175573","title":"Supernus Pharmaceuticals to Participate in March Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2613175573","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613175573?lang=en_us&edition=fundamental","pubTime":"2026-02-24 07:15","pubTimestamp":1771888500,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Feb.  23, 2026  (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3243119/19871/en/Supernus-Pharmaceuticals-to-Participate-in-March-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4135","BK4530","BK4121","BK4007","PD","BK4561","ADHD","LU1169590202.USD","SUPN","PPD","LU1169589451.USD","CNS"],"gpt_icon":0},{"id":"2613207987","title":"A Look At IQVIA Holdings (IQV) Valuation After Strong 2025 Results And New Obesity Research Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2613207987","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613207987?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:20","pubTimestamp":1771831219,"startTime":"0","endTime":"0","summary":"IQVIA Holdings (IQV) is back in focus after closing 2025 with revenue and EPS growth near double digits, record R&D Solutions net bookings, and a new obesity research collaboration with Duke Clinical Research Institute.\nSee our latest analysis for IQVIA Holdings.\nDespite the recent obesity research collaboration and solid year-end results, IQVIA Holdings’ share price has come under pressure, with a 30 day share price return of 29.62% and a 1 year total shareholder return of 13.31%. This...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/137473239-main-header/1756256222159","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/137473239-main-header/1756256222159"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/a-look-at-iqvia-holdings-iqv-valuation-after-strong-2025-res","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/a-look-at-iqvia-holdings-iqv-valuation-after-strong-2025-res","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0648001328.SGD","LU0980610538.SGD","LU1989764664.SGD","LU0130102774.USD","LU0130517989.USD","BK4530","LU1791710400.SGD","LU0477156953.USD","LU0130103400.USD","LU1261432733.SGD","BK4585","LU1791710582.SGD","LU0477156797.USD","LU0648000940.SGD","LU0882574055.USD","LU0528227936.USD","LU1201861165.SGD","BK4121","BK4588","IQV","LU1201861249.SGD","LU1989764748.USD","LU0198837287.USD","LU0130518102.USD"],"gpt_icon":0},{"id":"2612264257","title":"IQVIA Holdings Inc : Mizuho Cuts Target Price to $215 From $266","url":"https://stock-news.laohu8.com/highlight/detail?id=2612264257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612264257?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:54","pubTimestamp":1771592085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1989764664.SGD","LU0648001328.SGD","LU1201861165.SGD","LU0130518102.USD","LU0477156797.USD","BK4530","LU0130517989.USD","BK4585","LU0477156953.USD","BK4121","LU0882574055.USD","LU0130103400.USD","IQV","LU1791710582.SGD","BK4588","LU0198837287.USD","LU0980610538.SGD","LU1201861249.SGD","LU1791710400.SGD","LU1261432733.SGD","LU0130102774.USD","LU0528227936.USD","LU1989764748.USD","LU0648000940.SGD"],"gpt_icon":0},{"id":"2612268254","title":"Charles River Laboratories International Inc : TD Cowen Cuts Target Price to $235 From $251","url":"https://stock-news.laohu8.com/highlight/detail?id=2612268254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612268254?lang=en_us&edition=fundamental","pubTime":"2026-02-20 15:00","pubTimestamp":1771570815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG08P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0128526141.USD","CRL","LU0029874061.USD","LU1815336091.USD","BK4585","BK4530","BK4588","LU0390134368.USD","BK4121","LU0757428866.USD","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2612236085","title":"Gartner Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2612236085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612236085?lang=en_us&edition=fundamental","pubTime":"2026-02-20 06:17","pubTimestamp":1771539420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gartner Inc.  shed 2.67% to $156.94 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.28% to 6,861.89 and Dow Jones Industrial Average  falling 0.54% to 49,395.16.Gartner Inc. closed 69.43% below its 52-week high of $513.43, which the company reached on February 20th.The stock underperformed when compared to some of its competitors Thursday, as Trade Desk Inc. Cl A  fell 1.02% to $25.24, IQVIA Holdings Inc.  fell 0.99% to $169.36, and Omnicom Group Inc.  rose 15.36% to $80.94.Trading volume  remained 191,472 below its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 19, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","LU1201861165.SGD","LU0154245673.USD","LU1201861249.SGD","LU2362541273.HKD","LU0980610538.SGD","LU2357305700.SGD","LU0321505868.SGD","LU2362540622.SGD","BK4121","IT","LU0348723411.USD","BK4548","LU0731783048.USD","LU1720051108.HKD","LU0107464264.USD","LU0130103400.USD","LU1720051017.SGD","LU2517655291.USD","BK4528","BK4530","LU0772969993.USD","LU1509826696.USD","IE00BFXG1179.USD","BK4009","BK4588","LU0130102774.USD","LU0742537680.HKD","LU0130517989.USD","BK4023","LU0154245756.USD","LU1791710582.SGD","LU1989764748.USD","LU2362541513.USD","LU0882574055.USD","LU1791710400.SGD","OMC","LU1814569148.SGD","BK4613","LU1548497426.USD","TTD","LU0731783394.SGD","IQV","LU1989764664.SGD","LU2517655374.HKD","LU0477156953.USD","LU0528227936.USD","BK4134","LU0198837287.USD","LU1599440770.SGD"],"gpt_icon":0},{"id":"2612283436","title":"Charles River Labs Is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2612283436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612283436?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:24","pubTimestamp":1771511040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 19, 2026 09:24 ET (14:24 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFMHRM44.USD","LU0128526141.USD","CRL","BK4121","LU0390134368.USD","BK4530","LU0757428866.USD","BK4585","LU0029874061.USD","BK4588","LU1815336091.USD"],"gpt_icon":0},{"id":"2612128858","title":"Iqvia price target lowered to $245 from $290 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2612128858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612128858?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:35","pubTimestamp":1771508117,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Iqvia (IQV) to $245 from $290 and keeps a Buy rating on the shares. The firm is updating its model after ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iqvia-price-target-lowered-to-245-from-290-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iqvia-price-target-lowered-to-245-from-290-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","LU0130518102.USD","BK4585","BK4121","LU0648000940.SGD","LU0528227936.USD","LU0882574055.USD","LU0477156953.USD","BK4530","LU1261432733.SGD","IQV","LU1201861249.SGD","LU1791710400.SGD","LU0198837287.USD","LU0130517989.USD","LU0130103400.USD","LU1791710582.SGD","LU1989764748.USD","BK4588","LU0477156797.USD","LU0130102774.USD","LU0980610538.SGD","LU1989764664.SGD","LU0648001328.SGD"],"gpt_icon":0},{"id":"2612400128","title":"Charles River price target lowered to $200 from $260 at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2612400128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612400128?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:18","pubTimestamp":1771507091,"startTime":"0","endTime":"0","summary":"Evercore ISI lowered the firm’s price target on Charles River (CRL) to $200 from $260 and keeps an Outperform rating on the shares. Published first...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-lowered-to-200-from-260-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-lowered-to-200-from-260-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IE00BFMHRM44.USD","LU0029874061.USD","LU0390134368.USD","LU0757428866.USD","BK4530","CRL","LU1815336091.USD","LU0128526141.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2612404307","title":"Charles River Labs : Barclays Cuts Target Price to $200 From $215","url":"https://stock-news.laohu8.com/highlight/detail?id=2612404307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612404307?lang=en_us&edition=fundamental","pubTime":"2026-02-19 19:50","pubTimestamp":1771501822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nAZN4SHEHI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","LU0128526141.USD","LU0390134368.USD","BK4588","IE00BFMHRM44.USD","BK4585","LU0029874061.USD","CRL","LU0757428866.USD","BK4121","BK4530"],"gpt_icon":0},{"id":"2612472611","title":"Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2612472611","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612472611?lang=en_us&edition=fundamental","pubTime":"2026-02-19 14:01","pubTimestamp":1771480916,"startTime":"0","endTime":"0","summary":"Charles River Laboratories Intl (CRL) has disclosed a new risk, in the Corporate Activity and Growth category. The analyst notes that Charles River...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/strategic-review-at-charles-river-laboratories-raises-deal-uncertainty-execution-risks-and-shareholder-value-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/strategic-review-at-charles-river-laboratories-raises-deal-uncertainty-execution-risks-and-shareholder-value-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IE00BFMHRM44.USD","LU0029874061.USD","LU0390134368.USD","LU0757428866.USD","BK4530","CRL","LU1815336091.USD","LU0128526141.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2612479247","title":"Charles River Laboratories International Inc : Baird Cuts Target Price to $193 From $231","url":"https://stock-news.laohu8.com/highlight/detail?id=2612479247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612479247?lang=en_us&edition=fundamental","pubTime":"2026-02-19 12:19","pubTimestamp":1771474769,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZE0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0128526141.USD","BK4121","LU0757428866.USD","BK4530","LU0029874061.USD","LU1815336091.USD","LU0390134368.USD","CRL","BK4585","IE00BFMHRM44.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}